Patents Assigned to Key OBS
  • Medicament For the Treatment of Central Nervous System Disorders
    Publication number: 20080194631
    Abstract: The invention relates to the use of a molecule, alone or in combination, chosen from the group of molecules having a simultaneous antagonist action on the alpha1-noradrenergic, glutamatergic NMDA and serotoninergic 5HT2 receptors, for the preparation of a medicament intended for treating pathologies of the central nervous system.
    Type: Application
    Filed: July 26, 2005
    Publication date: August 14, 2008
    Applicants: Key OBS, Greenpharma
    Inventors: Fabrice Trovero, Philippe Bernard